BioSpace News Archive

Pharm Country

Axsome Therapeutics Joins Mental Health America and the State of New York to Raise Awareness of Mental Health During May is Mental Health Month

Axsome Therapeutics, Inc. is joining Mental Health America (MHA) and the State of New York to raise awareness of mental health during May is Mental Health Month.

May 1, 2023
·
7 min read
FDA

Cabaletta Bio Receives FDA Fast Track Designation for CABA-201

Cabaletta Bio, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for CABA-201, a 4-1BB-containing fully human CD19-CAR T cell investigational therapy.

May 1, 2023
·
8 min read
Biotech Beach

PreludeDx™ Presents Comparative Data at the Annual ASBrS Meeting Analyzing Racial/Ethnic Radiation Therapy Treatment Recommendation Changes using DCISionRT®

Prelude Corporation today announced new results evaluating the decision impact for radiation therapy (RT) recommendations incorporating the DCISionRT test by race (White vs. Black) in women with ductal carcinoma in situ (DCIS) enrolled in the PREDICT study.

May 1, 2023
·
5 min read
Drug Development

Zambon Completes Enrollment in Phase 3 Clinical Development Program Evaluating Liposomal Cyclosporine A for Inhalation (L-CsA-i) in Patients with Bronchiolitis Obliterans Syndrome (BOS)

Zambon announced today that the Company has completed enrollment in its two pivotal Phase 3 studies.

May 1, 2023
·
5 min read
Genetown

Verastem Oncology to Participate in Upcoming Investor Conferences

Verastem Oncology today announced that the Company will participate in the following upcoming investor conferences.

May 1, 2023
·
1 min read
Genetown

AlloVir to Present at the BofA Securities 2023 Health Care Conference

AlloVir, Inc. announced today that Diana Brainard, M.D., Chief Executive Officer, will participate in a fireside chat at the BofA Securities 2023 Health Care Conference in Las Vegas, NV on Tuesday, May 9, 2023, at 8:40 a.m. PDT.

May 1, 2023
·
1 min read
Genetown

Intellia Therapeutics Releases 2023 Corporate Responsibility Report Highlighting the Advancement of its Environmental, Social & Governance (ESG) Priorities

Intellia Therapeutics, Inc. today released its 2023 Corporate Responsibility report.

May 1, 2023
·
5 min read
Business

Cara Therapeutics to Announce First Quarter 2023 Financial Results on May 15, 2023

Cara Therapeutics, Inc. today announced the Company will host a conference call and live audio webcast on Monday, May 15, 2023, at 4:30 p.m. ET to report first quarter 2023 financial results and provide a corporate update.

May 1, 2023
·
1 min read
Biotech Bay

FibroGen Announces Non-Dilutive Term Loan Financing for up to $150 Million with Morgan Stanley Tactical Value

FibroGen, Inc. (NASDAQ: FGEN) today announced a non-dilutive term loan facility with investment funds managed by Morgan Stanley Tactical Value (MSTV) that will result in proceeds to FibroGen of up to $150 million, bringing significant non-dilutive capital to support growth and innovation.

May 1, 2023
·
4 min read
Bio NC

RedHill’s RHB-102 (BEKINDA®) and Opaganib Granted New Patents in Oncology Setting

RedHill Biopharma Ltd. (NASDAQ: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, today announced the granting of two new EU and U.S. patents for RHB-102 (BEKINDA)1 and opaganib2, respectively, in the oncology setting.

May 1, 2023
·
10 min read